CD4 and cancer: Both human patients and experimental animals with advanced cancer often exhibit a poorly functioning immune system [12-15], manifested by decreased T cell proliferation [16], alteration in signal-transducing molecules [17,18], reduced CD4+:CD8+ ratios, and deficient production of Th-1 cytokines [16,19,20].